Unbiased Analysis of Today's Healthcare Issues
As heard at ISPOR 2023 in Boston: On high US drug prices: “My hope as a European is that US never gets its health system in order.” And his Yoda-like pronouncement: “Affordability is important; but value is critical” Michael Drummond HT: Peter Neumann. See also Dr. Neumann’s ISPOR recap thread
An article from the Health Affairs forefront article from Ho and Vertinsky (2022) argues ‘yes’, but the use of any such such information for cost-based pricing is short-sighted. The Ho and Vertinsky say drug cost disclosure would be useful because (i) currently there is little information on the cost of drug development, (ii) it is…
That is the title of my article in MedCityNews. I discuss the evolution of value measurement, digital medicine, and the importance of reducing inequality. Below is an excerpt: While efficacy, safety and cost still form the core of a treatment’s value, how a treatment is administered is now becoming of primary importance in a world…
Cancer is a horrible disease. Providing high quality care often means providing safe, effective and cost-effective treatments that meets a patient’s priority. Reaching these goals, however, is particularly challenging when treating older adults with cancer. A paper on this exact topic by Ramsdale et al. (2017) notes that: Cancer care delivery for older adults with…
To find out the answer to this question, check out a live webinar on Wednesday, March 13th at 1:30pm EDT led by Dr. Anupam Jena, MD, PhD. Dr. Jena is a Harvard Professor and Precision Health Economics Scientific Advisor. In this unique one-hour webinar, Dr. Jena will outline a broader framework for assessing value to improve identification of not…
Seven CEOs from large pharmaceutical firms were brought before Congress today. And they got an earful from both Demogratic and Republican Congressmen. The executives were critique for selling too many opioids. They were critiqued for legal manuevers to extend brand name drugs’ patent life. But most of all, they were critiqued for high drug prices.…
Most products–especially commodities–are sold with a single price. You can buy an iPhone for largely the same price throughout the country. In the case of pharmaceuticals, however, there may be a case that prices should vary depending on their use. For instance, there may be a treatment which provides large benefits to patients with disease…
With co-authors Katalin Bognar, Michelle Brauer, Lauren Zhao, Rick Hockett, Michael O’Neil and Anupam Jena, I am excited to announce that our study “The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States” was published in the Journal of Medical Economics today. The full abstract is below. …
This is the title of an interesting commentary in Modern Healthcare by my colleague Mark Linthicum. An excerpt is below. In healthcare, different stakeholders have vastly different perceptions of value, with important implications for decisionmaking. An employer paying for healthcare may want to find solutions that decrease employee absences and prevent lengthy hospitalizations. A health…
An interesting article in Stat makes the important point that although there is much talk about “value” in the media and health policy world, the exact definition of “value” depends on your presepective. But a survey released Wednesday by the University of Utah shows that, in health care, value has no universal meaning — 88 percent of doctors…